Effects of Rasagiline on Sleep Disturbances in PD: A Single Center, Randomized, Double-blind, Placebo run-in, Polysomnographic Clinical Phase IV Trial

Trial Profile

Effects of Rasagiline on Sleep Disturbances in PD: A Single Center, Randomized, Double-blind, Placebo run-in, Polysomnographic Clinical Phase IV Trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Jun 2016

At a glance

  • Drugs Rasagiline (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms RaSPar
  • Most Recent Events

    • 19 Sep 2015 Status changed from recruiting to completed, as reported by European Clinical Trials Database (EudraCT) record.
    • 28 Jun 2014 Status changed from suspended to recruiting as reported by European Clinical Trials Database record.
    • 19 Apr 2014 Status changed from recruiting to suspended, as per European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top